Genmab A/S Files March 2024 6-K Report
Ticker: GNMSF · Form: 6-K · Filed: Mar 11, 2024 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Mar 11, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, registration-statement
Related Tickers: GMAB
TL;DR
Genmab filed a 6-K for March 2024, incorporating it into existing S-8 filings.
AI Summary
Genmab A/S filed a Form 6-K on March 11, 2024, to report information for the month of March 2024. This report is incorporated by reference into Genmab's existing S-8 registration statements (File Nos. 333-232693, 333-232693 and 333-262970). The filing includes standard information for a foreign private issuer.
Why It Matters
This filing serves as an update for investors and regulatory bodies, ensuring transparency regarding Genmab's ongoing reporting obligations.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — Registration Statement File Number
- 333-262970 (dollar_amount) — Registration Statement File Number
- March 2024 (date) — Reporting Period
- March 11, 2024 (date) — Filing Date
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is the reporting period for this Form 6-K?
The reporting period for this Form 6-K is the month of March 2024.
Which registration statements does this filing incorporate by reference?
This filing is incorporated by reference into Genmab A/S's registration statements on Form S-8, specifically File Nos. 333-232693, 333-232693 and 333-262970.
What is the principal executive office address of Genmab A/S?
The principal executive office address is Carl Jacobsens Vej 30, 2500 Valby, Denmark.
What is the SIC code for Genmab A/S?
The Standard Industrial Classification (SIC) code for Genmab A/S is 2834, Pharmaceutical Preparations.
Filing Stats: 232 words · 1 min read · ~1 pages · Grade level 13.6 · Accepted 2024-03-11 13:43:39
Filing Documents
- tmb-20240311x6k.htm (6-K) — 19KB
- tmb-20240311xex99d1.htm (EX-99.1) — 34KB
- tmb-20240311xex99d1a.htm (EX-99.1(A)) — 2066KB
- tmb-20240311xex99d1001.jpg (GRAPHIC) — 5KB
- tmb-20240311xex99d1a001.jpg (GRAPHIC) — 5KB
- 0001558370-24-002883.txt ( ) — 2133KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF MARCH 2024 COMMISSION FILE NUMBER 001-38976 Genmab A/S (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S's registration statements on Form S-8 (File No. 333-232693, 333-232693 and 333-262970 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. nthony GENMAB A/S BY: /s/ Anthony Pagano Name: Anthony Pagano Title: Executive Vice President & Chief Financial Officer DATE: MARCH 11, 2024 EXHIBIT INDEX O Exhibit Description of Exhibit 99.1 Company Announcement Dated March 11, 2024: Transactions in connection with share buy-back program 99.1(a) Appendix: Share Buy-Back Program Transactions March 4 to 8, 2024